Informationen:
Fehler:
ID
24013
Beschreibung
A Titration Study of a GLP-1 Analogue in Patients With Type 2 Diabetes Treated With Metformin.; ODM derived from: https://clinicaltrials.gov/show/NCT00460941
Link
https://clinicaltrials.gov/show/NCT00460941
Stichworte
Versionen (1)
- 22.07.17 22.07.17 -
Hochgeladen am
22. Juli 2017
DOI
Für eine Beantragung loggen Sie sich ein.
Lizenz
Creative Commons BY 4.0
Modell Kommentare :
Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.
Itemgroup Kommentare für :
Item Kommentare für :
Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.
Eligibility Diabetes Mellitus, Type 2 NCT00460941
Eligibility Diabetes Mellitus, Type 2 NCT00460941
- StudyEvent: Eligibility
Ähnliche Modelle
Eligibility Diabetes Mellitus, Type 2 NCT00460941
- StudyEvent: Eligibility
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Gender | Postmenopausal state | Female Sterilization | Age
Item
male,and post-menopausal or surgically sterilized female, patients, 18-75 years of age;
boolean
C0079399 (UMLS CUI [1])
C0232970 (UMLS CUI [2])
C0015787 (UMLS CUI [3])
C0001779 (UMLS CUI [4])
C0232970 (UMLS CUI [2])
C0015787 (UMLS CUI [3])
C0001779 (UMLS CUI [4])
Diabetes Mellitus, Non-Insulin-Dependent | Metformin Stable
Item
type 2 diabetes mellitus, with stable metformin treatment for >=3 months;
boolean
C0011860 (UMLS CUI [1])
C0025598 (UMLS CUI [2,1])
C0205360 (UMLS CUI [2,2])
C0025598 (UMLS CUI [2,1])
C0205360 (UMLS CUI [2,2])
Glycosylated hemoglobin A
Item
hba1c >=7.0% and <=9.5% at screening;
boolean
C0019018 (UMLS CUI [1])
Stable body weight
Item
stable weight +/-10% for >=3 months before screening.
boolean
C0517386 (UMLS CUI [1])
Diabetes Mellitus, Insulin-Dependent
Item
type 1 diabetes mellitus;
boolean
C0011854 (UMLS CUI [1])
Gastrointestinal Diseases
Item
clinically significant gastrointestinal disease;
boolean
C0017178 (UMLS CUI [1])
Hypoglycemic Agents | Metformin Excluded
Item
treatment with any anti-hyperglycemic medication other than metformin monotherapy during last 3 months;
boolean
C0020616 (UMLS CUI [1])
C0025598 (UMLS CUI [2,1])
C2828389 (UMLS CUI [2,2])
C0025598 (UMLS CUI [2,1])
C2828389 (UMLS CUI [2,2])
Weight-Loss Agents
Item
use of weight-lowering medications in the last 3 months;
boolean
C0376606 (UMLS CUI [1])
Uncontrolled hypertension
Item
uncontrolled hypertension;
boolean
C1868885 (UMLS CUI [1])
Exposure to Glucagon-Like Peptide 1 | Exposure to Glucagon-Like Peptide 1 Analogue
Item
previous exposure to glp-1 or glp-1 analogues.
boolean
C0332157 (UMLS CUI [1,1])
C0061355 (UMLS CUI [1,2])
C0332157 (UMLS CUI [2,1])
C0061355 (UMLS CUI [2,2])
C0243071 (UMLS CUI [2,3])
C0061355 (UMLS CUI [1,2])
C0332157 (UMLS CUI [2,1])
C0061355 (UMLS CUI [2,2])
C0243071 (UMLS CUI [2,3])